Feedback / Questions
Myoconda (clarithromycin/clofazimine/rifabutin) - RedHill
RedHill: Corporate Presentation
(RedHill)
-
Aug 6, 2016 -
Anticipated DSMB safety and futility analysis of P3 MAP US trial (NCT01951326) for Crohn’s disease in Q4 2016
Anticipated DSMB
•
Inflammatory Bowel Disease
http://ir.redhillbio.com/
Aug 6, 2016
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious